Literature DB >> 4077271

Group C streptococcal endocarditis: case report and review of the literature.

D S Stein, A P Panwalker.   

Abstract

Human infections due to group C streptococci are rare. We describe here a patient with endocarditis caused by this organism. A review of 16 other cases of group C streptococcal endocarditis reported in the literature suggests that this organism has a high potential for attachment to and destruction of normal heart valves. Major emboli to vital organs are frequently observed and the mortality has been high. Synergistic combinations of penicillin and an aminoglycoside appear to result in lower morbidity as compared to penicillin used alone. Early valve replacement may reduce the mortality in this extremely serious infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077271     DOI: 10.1007/BF01645440

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  25 in total

1.  Lancefield group C streptococcal endocarditis.

Authors:  P Finnegan; M X Fitzgerald; G Cumming; A M Geddes
Journal:  Thorax       Date:  1974-03       Impact factor: 9.139

2.  Antibiotic-killing kinetics of group B streptococci.

Authors:  V Schauf; A Deveikis; L Riff; A Serota
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

3.  Bacterial endocarditis due to a penicillin-tolerant group C streptococcus.

Authors:  D Portnoy; I Wink; G K Richards; M Z Blanc
Journal:  Can Med Assoc J       Date:  1980-01-12       Impact factor: 8.262

4.  Group C streptococcal endocarditis.

Authors:  J Brown; D Savage
Journal:  South Med J       Date:  1980-01       Impact factor: 0.954

5.  Activity of nine antimicrobial agents against Lancefield group C and group G streptococci.

Authors:  K V Rolston; J L LeFrock; R F Schell
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

6.  Single-antibiotic therapy for streptococcal endocarditis.

Authors:  A W Karchmer; R C Moellering; D G Maki; M N Swartz
Journal:  JAMA       Date:  1979-04-27       Impact factor: 56.272

7.  Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.

Authors:  W R Wilson; C J Wilkowske; A J Wright; M A Sande; J E Geraci
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

8.  [Acute bacterial endocarditis caused by streptococci of Lancefield group C (author's transl)].

Authors:  O M Hess; P Rüegg; J Kugelmeier; M Turina; H P Biedermann; P C Baumann
Journal:  Dtsch Med Wochenschr       Date:  1979-12-07       Impact factor: 0.628

9.  Group C streptococcal endocarditis associated with intubation-induced tracheal stenosis.

Authors:  C M Jack; M M Khan; A A Adgey
Journal:  Int J Cardiol       Date:  1984-03       Impact factor: 4.164

10.  Serious infection caused by group C streptococci.

Authors:  A T Ghoneim; E M Cooke
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

View more
  2 in total

1.  Group C streptococci in human infection: a study of 308 isolates with clinical correlations.

Authors:  M Barnham; J Kerby; R S Chandler; M R Millar
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

2.  Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes.

Authors:  T Zaoutis; B Schneider; L Steele Moore; J D Klein
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.